4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0001193125-26-002448
Chief Financial Officer sold 6,294 shares at $27.10 ($170,567)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Emany Sravan Kumar Chief Financial Officer | 2025-12-31 | Sale 10b5-1 | −6,294 | $27.10 | $170,567 | 73,706 | D: show line 1 in the form |
| Open-market sales · 6,294 sh · avg $27.10 · $170,567 | |||||||
Loading xslF345X05/ownership.xml…